Related references
Note: Only part of the references are listed.Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer
Michal Vocka et al.
CANCER BIOMARKERS (2018)
Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass
Piotr Hogendorf et al.
CANCER BIOMARKERS (2018)
Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
Kai C. Wollert et al.
CLINICAL CHEMISTRY (2017)
Current and future biomarkers for pancreatic adenocarcinoma
Sven H. Loosen et al.
TUMOR BIOLOGY (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer
Chen Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma
O. M. Fisher et al.
BRITISH JOURNAL OF CANCER (2015)
Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality
Raaj S. Mehta et al.
GASTROENTEROLOGY (2015)
GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective
Ramu Adela et al.
JOURNAL OF DIABETES RESEARCH (2015)
Association of Serum Level of Growth Differentiation Factor 15 with Liver Cirrhosis and Hepatocellular Carcinoma
Xiuying Liu et al.
PLOS ONE (2015)
Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma
Xiaobing Wang et al.
BMC CANCER (2014)
Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy
Xiao-Bing Wang et al.
CANCER SCIENCE (2014)
Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer
Moises Blanco-Calvo et al.
FUTURE ONCOLOGY (2014)
Potentials of Plasma NGAL and MIC-1 as Biomarker(s) in the Diagnosis of Lethal Pancreatic Cancer
Sukhwinder Kaur et al.
PLOS ONE (2013)
Macrophage Inhibitory Cytokine-1: A review of its pleiotropic actions in cancer
Yazan S. Khaled et al.
CANCER BIOMARKERS (2012)
Serum Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15): A Potential Screening Tool for the Prevention of Colon Cancer?
David A. Brown et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
U. Wallin et al.
BRITISH JOURNAL OF CANCER (2011)
Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer
R. J. E. Skipworth et al.
BRITISH JOURNAL OF CANCER (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
The TGF-β Superfamily Cytokine MIC-1/GDF15: Secretory Mechanisms Facilitate Creation of Latent Stromal Stores
Asne R. Bauskin et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Guidelines for Diagnostic Tests and Diagnostic Accuracy in Surgical Research
Catherine M. Jones et al.
JOURNAL OF INVESTIGATIVE SURGERY (2010)
Identification of Serum Biomarkers for Colorectal Cancer Metastasis Using a Differential Secretome Approach
Hua Xue et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Macrophage Inhibitory Cytokine-1: Possible Bridge Molecule of Inflammation and Prostate Cancer
Dev Karan et al.
CANCER RESEARCH (2009)
Interpretation of tests of heterogeneity and bias in meta-analysis
John P. A. Ioannidis
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2008)
Serum markers in patients with resectable pancreatic adenocarcinoma: Macrophage inhibitory cytokine 1 versus CA19-9
J Koopmann et al.
CLINICAL CANCER RESEARCH (2006)
Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers
J Koopmann et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
